Работы, цитирующие эту работу

Работ: 2

Работа: Development of NK cell-based cancer immunotherapies through receptor engineering

1. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   СтатьяCAR-T cell therapy researchJournal of Hematology & Oncology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.000083

2. New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK

   Saade Abdalkareem Jasim, Harikumar Pallathadka, G. V. Sivaprasad +7

   Обзорная статьяCAR-T cell therapy researchFunctional & Integrative Genomics2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000133